Ad
related to: bristol-myers- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Search results
Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy
Simply Wall St. via Yahoo Finance· 2 days agoOver the past year, many Bristol-Myers Squibb Company (NYSE:BMY) insiders sold a significant stake...
Bristol Myers Squibb to cut 862 NJ workers as part of $1.5B cost-savings plan
NJBIZ· 3 days agoAs part of a larger restructuring effort, Princeton-based pharma giant Bristol Myers Squibb plans to...
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
Zacks via Yahoo Finance· 6 days agoThe latest trading session saw Bristol Myers Squibb (BMY) ending at $41.77, denoting a +1.65%...
Rockville’s I-Mab, Bristol Myers Squibb to collaborate on new cancer study - Maryland Daily Record
The Daily Record· 5 days agoUnder the terms of the agreement, the study will be a multi-national Phase 1 study conducted by I-Mab. Bristol Myers Squibb will supply nivolumab. Nivolumab is an immune checkpoint ...
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Envestnet Asset Management Inc.
ETF DAILY NEWS· 23 hours agoEnvestnet Asset Management Inc. lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.4% during the 4th quarter, according to its most recent ...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 7 days agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients - ...
Benzinga· 6 days agoOpdivo plus Yervoy combo shows significant survival benefits and higher response rates vs....
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 5 days agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 6 days agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 6 days agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...